Filing Flows › Comparisons › CCEL vs MRAI
Cryo Cell International vs Marpai: CCEL and MRAI compared
Cryo Cell International is the larger company: $7.8M of revenue in its latest quarter (Q3 FY26) against $4.2M for Marpai (Q2 2026). Cryo Cell International is growing faster (0% against -10% a year earlier). Cryo Cell International is more profitable, with an operating margin of 28.0% against -82.4%.
Where the money goes: CCEL and MRAI
Cryo Cell International (CCEL) · Q3 FY26
Cryo Cell International, Q3 FY26: revenue $7.8M (0% year over year), operating margin 28.0%, net earnings $1.3M, operating cash flow $1.1M. The chart follows the revenue to costs, profit and cash.
Marpai (MRAI) · Q2 2026
Marpai, Q2 2026: revenue $4.2M (-10% year over year), operating margin -82.4%, net loss $4.6M, operating cash flow −$4.1M. The chart follows the revenue to costs, profit and cash.
| Cryo Cell International (CCEL) | Marpai (MRAI) | |
|---|---|---|
| Latest quarter | Q3 FY26 | Q2 2026 |
| Revenue | $7.8M | $4.2M |
| Revenue growth, Y/Y | 0% | -10% |
| Operating margin | 28.0% | -82.4% |
| Net earnings | $1.3M | −$4.6M |
| Net margin | 16.2% | -110.0% |
| Operating cash flow | $1.1M | −$4.1M |
| Free cash flow | $1.0M | — |
Where the revenue comes from
Cryo Cell International
- Processing and Storage Fees: $7.7M (98%)
- Public Banking: $135K (2%)
- Product: $39K (0%)
Questions
Which is bigger, Cryo Cell International or Marpai?
Cryo Cell International is the larger company: $7.8M of revenue in its latest quarter (Q3 FY26) against $4.2M for Marpai (Q2 2026).
Is Cryo Cell International or Marpai growing faster?
Cryo Cell International is growing faster (0% against -10% a year earlier).
Which is more profitable, Cryo Cell International or Marpai?
Cryo Cell International is more profitable, with an operating margin of 28.0% against -82.4%.
More: Cryo Cell International earnings · how Cryo Cell International makes money · Marpai earnings · how Marpai makes money
From the companies' latest 10-Q, 10-K or earnings release (10-Q filed Oct 9, 2026; 10-Q filed Aug 13, 2026). Fiscal quarters can end on different dates. Not investment advice.